| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.01 |